Alder's mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. Alder plays two roles: As a biopharmaceutical company, Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. The work being done at Alder today will help those who suffer from cancer, autoimmune diseases, and inflammatory diseases. As a licensing partner, Alder is revolutionizing the way the pharmaceutical industry discovers, develops and produces antibody therapeutics. Through various licensing agreements, Alder has used its proprietary technology to help major biopharmaceutical partners advance novel therapeutics to the clinic in less time and at lower cost. Alder's licensing strategy also includes identifying strategic partners to assist in the development and marketing of its preclinical and clinical pipeline programs.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is market cap of Alder BioPharmaceuticals Inc?
The market cap of Alder BioPharmaceuticals Inc is N/A
What is the 52 week high for Alder BioPharmaceuticals Inc?
The 52 week high for Alder BioPharmaceuticals Inc is N/A.
What is the 52 week low for Alder BioPharmaceuticals Inc?
The 52 week low for Alder BioPharmaceuticals Inc is N/A.
What is the pe ratio of Alder BioPharmaceuticals Inc?
The PE ratio of Alder BioPharmaceuticals Inc is None.
What is the price to book ratio of Alder BioPharmaceuticals Inc?
The price to book ratio of Alder BioPharmaceuticals Inc is None.
What is Alder BioPharmaceuticals Inc's EBITDA?
Alder BioPharmaceuticals Inc's EBITDA is -303.616.
What is the 50-day moving average of Alder BioPharmaceuticals Inc?
The 50-day moving average of Alder BioPharmaceuticals Inc is None.
How many employess does Alder BioPharmaceuticals Inc has?